Strategies for Delaying or Treating<i>In vivo</i>Acquired Resistance to Trastuzumab in Human Breast Cancer Xenografts
2006 · Clinical Cancer Research · 144 citations
https://doi.org/10.1158/1078-0432.ccr-05-1109
J
Jeffrey A. Medin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
283
Papers
7.6K
Citations
45
h-index
132
i10-index
Jeffrey A. Medin is an academic researcher from Medical College of Wisconsin. The author has contributed to research in topics: Virus-based gene therapy research & Lysosomal Storage Disorders Research & CAR-T cell therapy research. The author has an h-index of 45, co-authored 241 publications.
ORCID: 0000-0001-8165-8995Papers by this author
worksLentivector Iterations and Pre-Clinical Scale-Up/Toxicity Testing: Targeting Mobilized CD34 + Cells for Correction of Fabry Disease
2017 · Molecular Therapy — Methods & Clinical Development · 45 citations
https://doi.org/10.1016/j.omtm.2017.05.003
Tumor Protection Following Vaccination With Low Doses of Lentivirally Transduced DCs Expressing the Self-antigen erbB2
2008 · Molecular Therapy · 28 citations
https://doi.org/10.1038/sj.mt.6300390
Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using β-human choriogonadotropin secreting tumor cell lines
2008 · Molecular Cancer Therapeutics · 27 citations
https://doi.org/10.1158/1535-7163.mct-08-0200
Lentivector Transduction Improves Outcomes Over Transplantation of Human HSCs Alone in NOD/SCID/Fabry Mice
2012 · Molecular Therapy · 24 citations
https://doi.org/10.1038/mt.2012.64
Azidothymidine-triphosphate impairs mitochondrial dynamics by disrupting the quality control system
2017 · Redox Biology · 22 citations
https://doi.org/10.1016/j.redox.2017.06.011
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat